DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "IMS Pharmaceutical Pricing & Reimbursement Concise Guide: Netherlands" report to their offering.
The Pharmaceutical Pricing & Reimbursement Concise Guides are established as the definitive reference and training text for P&R professionals around the world, drawing on the long-standing expertise of pricing and reimbursement specialists to provide industry players and decision makers with a thorough understanding of the rules and regulations governing P&R in international markets.
This report covers key developments in P&R, market access, cost containment, trade margins and healthcare issues.
Key Topics Covered:
1. HEALTHCARE SYSTEM
Facts & Figures
Market Indicators
Provision & Funding
Basic Health Insurance
Supplementary Health Insurance
Long-term Care
2. PRICING
Prescription Drugs
WGP Methodology
WGP Price Revisions
Pricing Agreements
Generic Drugs
Hospital Drugs
Pricing Rules
Price Negotiations and Tendering
Controversy over Hospital Medicines Prices
Joint Purchasing Schemes
Cross-border Procurement
OTC Drugs
3. REIMBURSEMENT
Admission to Reimbursement
Pre-assessment Process
Reimbursement Applications
Assessment
Decision
Appeals
Provisional Reimbursement
Barriers to Access
Reassessments
Changes in Reimbursement Prices
4. PHARMACOECONOMICS
Pharmacoeconomic Requirements
Mandatory Requirement
Exemptions
Pharmacoeconomic Guidelines
Proposed QALY Threshold
Hospital Drugs
Orphan Drugs
Provisional Reimbursement
5. PRICE BUILD UP
Retail Pharmacies
Pharmacy Remuneration
Discounts
Clawback System
Pharmacy Chains
OTC Sales
E-pharmacy
Supply Shortages
Dispensing Doctors
Sales Tax
6. COST CONTAINMENT
Industry Paybacks
Promotional Costs
Patient Co-payments
Deductible
Other Charges for Prescription Medicines
Prescribing Controls
Treatment Guidelines
Targets
7. FUTURE DEVELOPMENTS
Outlook
Drug Pricing
Medicines Policy Plan
Cross-border Co-operation
Cost-effectiveness Threshold
8. NAMES & ADDRESSES
For more information about this report visit http://www.researchandmarkets.com/research/bxn3fj/ims
